New Straits Times OnlineCRISPR-Cas9 corrects hypertrophic cardiomyopathy gene mutation in human preimplantation embryos [PreClinical]2 Minute MedicineThis study was the first to use CRISPR-Cas9 to correct a harmful mutation without causing significant … Continue reading
The Australian |
CSL buys stem cell therapy firm Calimmune
The Australian The purchase of US-based biotech Calimmune will expand the offering of CSL Behring, which is the plasma arm of CSL focused on treatments for haemophilia. Calimmune’s lead development programs are ex vivo haematopoietic stem cell (HSC) gene … CSL acquires biotech company & stem cell gene platformFinance News Network Is CSL Limited buying its way to growth?Motley Fool Australia In The NewsSwitzer Financial News |
|
CSL buys stem cell therapy firm Calimmune
SBS The acquisition will provide CSL Behring, CSL’s blood products business, with Calimmune’s haematopoietic stem cell gene therapy which is being developed for the treatment of sickle cell disease and b-thalassemia. The deal requires an an up-front … |
NEWS.com.au |
CSL buys stem cell therapy firm Calimmune
NEWS.com.au The acquisition will provide CSL Behring, CSL’s blood products business, with Calimmune’s haematopoietic stem cell gene therapy which is being developed for the treatment of sickle cell disease and b-thalassemia. The deal requires an an up-front … CSL acquires biotech company & stem cell gene platformFinance News Network Is CSL Limited buying its way to growth?Motley Fool Australia In The NewsSwitzer Financial News |